Economic Development

10 great cities for raising families

News Outlet: 
Kiplinger's Personal Finance Magazine
Date published: 
August 30, 2010

Huntsville was named one of the country's top 10 cities for raising families by Kiplinger's.

Read the full article to see why Huntsville made the list.

 

 

Rise of individualized medicine helps Clarient

News Outlet: 
BioMedReports
Date published: 
August 9, 2010
Download PDF: 

By Patrick Crutcher  

This small-cap company may be poised to be a long-term leader in cancer diagnostics and molecular testing. They combine innovative diagnostic technologies with world-class pathology expertise to assess and characterize cancer. The rise of individualized medicine as the new direction in oncology has created the need for a centralized resource providing leading diagnostic technologies, such as flow cytometry and molecular testing.

CFDRC to demonstrate its Bio‐Battery technology at 44th Power Sources Conference

Las Vegas, Nevada, June 14‐17

Huntsville, Ala. - CFD Research Corporation (CFDRC), a high‐tech small business developing innovative 
technologies for military and commercial markets, will be demonstrating its award winning Bio‐Battery 
technology at the 44th Power Sources Conference in Las Vegas, Nev. The Bio‐Battery is a novel
 micropower source which harvests energy from biological fuels such as sugars and converts them into
 electrical energy providing a sustained, on‐demand power source. The product is adaptable for many
 low power applications in both the military and commercial markets. CFDRC’s Bio‐Battery offers several
 advantages over conventional fuel cells and batteries; including reduced size and weight, instant
 recharge, flexible shape, renewable biocatalysts, environmental‐friendliness, room temperature 
operation, and readily available fuel source.

Diatherix Laboratories rolls out gastrointestinal test panel

News Outlet: 
Medical Devices Business Review
Date published: 
March 30, 2010
Download PDF: 

Diatherix Laboratories has added a gastrointestinal (GI) panel to its lineup of sensitive, response diagnostic tests. Diatherix GI panel can detect and differentiate nine types of GI infections and helps physicians to identify severe, life-threatening infections in patients.

The GI panel provides physicians with accurate test results in one day by which patients can be more effectively treated through targeted therapeutics which reduces overall medical costs and a patient's down time.

Hospital partnership could speed up diagnosis of infectious diseases

News Outlet: 
Dayton Daily News
Date published: 
March 12, 2010
Download PDF: 

Kettering Medical Center working with Alabama company to improve care, save money.

By Ben Sutherly
Staff Writer

KETTERING — Kettering Medical Center expects a partnership with an infectious disease diagnostic company to improve patient care and save the hospital money through more rapid diagnoses.

HudsonAlpha supports city’s bid for Google fiber

Institute part of Get Google task force
 
“I want a gig in Huntsville,” announced Dr. O’Neal Smitherman, executive vice president of the HudsonAlpha Institute for Biotechnology and member of Huntsville’s Get Google task force. Smitherman spoke at a press conference hosted by Huntsville Mayor Tommy Battle on Monday, March 15.

Alabama's economy: After cotton

News Outlet: 
The Economist
Date published: 
March 11, 2010
Download PDF: 

Alabama’s small cities are poised for recovery

TUCKED between the Tombigbee river and a rural highway meandering north from Mobile sits a warren of huge buildings in Willy Wonka-colours: sea-foam blue and green, desert beige and mauve. Though they look like a modern-art installation, in fact they comprise a new steel mill being built by ThyssenKrupp, a German company. According to ThyssenKrupp the $3.7 billion mill represents the largest German investment in America ever. When it reaches full capacity in 2012, it will employ 2,700 workers and produce some 5.1m tons of carbon and stainless steel per year.

Clarient launches new lung cancer test

News Outlet: 
Clarient Investor Relations
Date published: 
February 10, 2010
Download PDF: 

Clarient Insight Dx Pulmotype is the first commercial test launched following the recent acquisition of HudsonAlpha resident associate Applied Genomics Inc.  AGI developed Pulmotype and recently validated the test with a clinical study cohort of more than 1,000 patients.  The peer-reviewed results were published in the August 2009 edition of Modern Pathology.  A link to that study can be accessed at www.clarientinc.com/pulmotype.

A stronger lifeline

News Outlet: 
The Huntsville Times R&D Report
Date published: 
January 3, 2010
Download PDF: 

The Huntsville Times R&D Report
By Diana LaChance

Award-winning kidney dialysis catheter is easier on patients.

When it comes to biomedical innovation, it can be hard to change the existing paradigm.  Doctors - and insurance companies - tend to stick with what they know, with what has been proven to work in the past.  So it takes a special product to get the medical establishment to sit up and take notice.  B. Prabhakar Pandian, a principal scientist and director of the Bioengineering Laboratory at CFD Research Corp. (CFDRC), believes that he and his fellow researchers have come up with just that in their patented hemodialysis catheter.  "Most of the catheters on the market have a major recirculation problem," says Pandian.  So CFDRC's researchers set out to create an improved catheter that would minimize this inherent problem.  Not only did they achieve their goal, but they also managed to solve a few other problems along the way.

Resident associate AGI acquired by Clarient

News Outlet: 
PR Newswire
Date published: 
December 21, 2009

“We are extremely excited to expand our industry leading cancer characterization capabilities to the Huntsville area. Applied Genomics will add significant capabilities that fill a gap in our corporate offering. Clearly, having connectivity to the state of the art Hudson Alpha Institute and its genomic discovery capabilities was an attractive component in our search for the right development partner. We are enthusiastic about the short and long term opportunities of this deal.”

—Ron Andrews, chief executive officer, Clarient, Inc.

Syndicate content